FOP News - IFOPA - International Fibrodysplasia Ossificans Progressiva Association

FOP News

IFOPA-funded Gene Therapy Research Published in Nature Communications

Posted by · November 17, 2022 1:17 PM

Read more Share

Announcement from BioCryst Pharmaceuticals About BCX9250

Posted by · November 01, 2022 7:04 AM

Read more Share

IPSEN Publishes Burden of Illness Study and Releases Plain Language Summary

Posted by · October 31, 2022 1:12 PM

Read more Share

Ipsen's FOP Natural History Study Published in the Genetics in Medicine Journal

Posted by · September 30, 2022 3:49 PM

Read more Share

18 FOP and HO Sessions and Posters Featured at the ASBMR 2022 Annual Meeting

Posted by · September 24, 2022 3:29 PM

Read more Share

BioCryst Pharmaceuticals Granted Orphan Drug Designation from U.S. FDA for BCX9250

Posted by · September 01, 2022 9:04 AM

Read more Share

You’re Invited to Submit Written Testimony to the US FDA

Posted by · August 24, 2022 8:10 AM

Read more Share

Ipsen's Resubmission to the US Food & Drug Administration is Accepted

Posted by · June 29, 2022 6:50 AM

Read more Share

BioCryst Pharmaceuticals Receives Fast Track Designation from U.S. FDA for BCX9250

Posted by · June 22, 2022 11:39 AM

Read more Share

Important Updates in FOP Clinical Trials

Posted by · June 21, 2022 1:23 PM

Read more Share

«
1
2
3
4
5
6
7
8
9
»

Learn More

Is it FOP? Just Diagnosed Registry

Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter